Jeffrey D. Leimberger
About
Jeffrey D. Leimberger is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and General Health Professions.
According to data from OpenAlex, Jeffrey D. Leimberger has authored 37 papers receiving a total of 5.9k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Cardiology and Cardiovascular Medicine, 7 papers in Surgery and 4 papers in General Health Professions. Recurrent topics in Jeffrey D. Leimberger's work include Heart Failure Treatment and Management (18 papers), Cardiovascular Function and Risk Factors (12 papers) and Acute Myocardial Infarction Research (9 papers). Jeffrey D. Leimberger is often cited by papers focused on Heart Failure Treatment and Management (18 papers), Cardiovascular Function and Risk Factors (12 papers) and Acute Myocardial Infarction Research (9 papers). Jeffrey D. Leimberger collaborates with scholars based in United States, Canada and United Kingdom. Jeffrey D. Leimberger's co-authors include Robert M. Califf, Marc A. Pfeffer, John J.V. McMurray, Eric J. Velazquez, Lars Køber, Jean‐Lucien Rouleau, Scott D. Solomon, Aldo P. Maggioni, Steven L. Zelenkofske and Harvey D. White and has published in prestigious journals such as New England Journal of Medicine, Circulation and Journal of the American College of Cardiology.
In The Last Decade
Jeffrey D. Leimberger
37 papers receiving 5.6k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Jeffrey D. Leimberger United States | 22 | 4.3k | 1.0k | 981 | 850 | 748 | 37 | 5.9k | ||
| Jan Skov Jensen Denmark | 43 | 5.1k 1.2× | 1.4k 1.4× | 783 0.8× | 1.3k 1.5× | 1.6k 2.1× | 188 | 8.1k | ||
| Carlo Lombardi Italy | 36 | 2.7k 0.6× | 431 0.4× | 1.3k 1.3× | 663 0.8× | 359 0.5× | 216 | 5.9k | ||
| Shih‐Jen Hwang United States | 38 | 3.1k 0.7× | 995 1.0× | 699 0.7× | 871 1.0× | 1.1k 1.5× | 102 | 6.4k | ||
| Haldun Müderrisoğlu Türkiye | 36 | 2.9k 0.7× | 426 0.4× | 712 0.7× | 1.3k 1.5× | 300 0.4× | 329 | 4.8k | ||
| Giovanni Parrinello Italy | 36 | 3.3k 0.8× | 399 0.4× | 641 0.7× | 1.9k 2.3× | 208 0.3× | 70 | 5.3k | ||
| Patricia P. Chang United States | 27 | 2.6k 0.6× | 423 0.4× | 416 0.4× | 394 0.5× | 499 0.7× | 103 | 4.0k | ||
| Patricia A. Peyser United States | 38 | 1.8k 0.4× | 408 0.4× | 658 0.7× | 947 1.1× | 618 0.8× | 92 | 4.5k | ||
| Christina L. Wassel United States | 36 | 1.1k 0.2× | 657 0.6× | 522 0.5× | 807 0.9× | 410 0.5× | 101 | 3.6k | ||
| Michelle J. Keyes United States | 33 | 4.0k 0.9× | 228 0.2× | 1.0k 1.0× | 1.4k 1.7× | 1.2k 1.6× | 57 | 6.9k | ||
| Jørgen Jeppesen Denmark | 34 | 3.1k 0.7× | 231 0.2× | 631 0.6× | 852 1.0× | 1.2k 1.7× | 110 | 5.4k |
Countries citing papers authored by Jeffrey D. Leimberger
Since
Specialization
Citations
This map shows the geographic impact of Jeffrey D. Leimberger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey D. Leimberger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey D. Leimberger more than expected).
Fields of papers citing papers by Jeffrey D. Leimberger
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Jeffrey D. Leimberger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey D. Leimberger. The network helps show where Jeffrey D. Leimberger may publish in the future.
Co-authorship network of co-authors of Jeffrey D. Leimberger
This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey D. Leimberger. A scholar is included among the top collaborators of Jeffrey D. Leimberger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey D. Leimberger. Jeffrey D. Leimberger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Diepen, Sean van, Rajendra H. Mehta, Jeffrey D. Leimberger, et al.. (2019). Levosimendan in patients with reduced left ventricular function undergoing isolated coronary or valve surgery. Journal of Thoracic and Cardiovascular Surgery. 159(6). 2302–2309.e6.
2.
Mehta, Rajendra H., Sean van Diepen, James P. Meza, et al.. (2016). Levosimendan in patients with left ventricular systolic dysfunction undergoing cardiac surgery on cardiopulmonary bypass: Rationale and study design of the Levosimendan in Patients with Left Ventricular Systolic Dysfunction Undergoing Cardiac Surgery Requiring Cardiopulmonary Bypass (LEVO-CTS) trial. American Heart Journal. 182. 62–71.
3.
Leimberger, Jeffrey D., Karen Chiswell, W. Schuyler Jones, et al.. (2015). Clinical characteristics and outcomes after unplanned intraaortic balloon counterpulsation in the Counterpulsation to Reduce Infarct Size Pre-PCI Acute Myocardial Infarction trial. American Heart Journal. 174. 7–13.
4.
Winhusen, Theresa, Eugene Somoza, Gregory S. Brigham, et al.. (2010). Impact of Attention-Deficit/Hyperactivity Disorder (ADHD) Treatment on Smoking Cessation Intervention in ADHD Smokers. The Journal of Clinical Psychiatry. 71(12). 1680–1688.
5.
Taekman, Jeffrey M., Mark Stafford‐Smith, Eric J. Velazquez, et al.. (2010). Departures from the protocol during conduct of a clinical trial: a pattern from the data record consistent with a learning curve. BMJ Quality & Safety. 19(5). 405–410.
6.
Califf, Robert M., Yuliya Lokhnygina, Eric J. Velazquez, et al.. (2009). Usefulness of Beta Blockers in High-Risk Patients After Myocardial Infarction in Conjunction With Captopril and/or Valsartan (from the VALsartan In Acute Myocardial Infarction [VALIANT] Trial). The American Journal of Cardiology. 104(2). 151–157.
7.
Køber, Lars, Karl Swedberg, John J.V. McMurray, et al.. (2006). Previously Known and Newly Diagnosed Atrial Fibrillation: A Major Risk Indicator After a Myocardial Infarction Complicated by Heart Failure or Left Ventricular Dysfunction. European Journal of Heart Failure. 8(6). 591–598.
8.
Felker, G. Michael, Jeffrey D. Leimberger, Robert M. Califf, et al.. (2004). Risk stratification after hospitalization for decompensated heart failure. Journal of Cardiac Failure. 10(6). 460–466.
9.
Anavekar, Nagesh S., John J.V. McMurray, Eric J. Velazquez, et al.. (2004). Relation between Renal Dysfunction and Cardiovascular Outcomes after Myocardial Infarction. New England Journal of Medicine. 351(13). 1285–1295.
10.
Aguilar, David, Scott D. Solomon, Lars Køber, et al.. (2003). Impact of known and newly diagnosed diabetes mellitus after a myocardial infarction. Journal of the American College of Cardiology. 41(6). 345–346.
11.
Felker, G. Michael, Raymond L. Benza, A. Bleakley Chandler, et al.. (2003). Heart failure etiology and response tomilrinone in decompensated heart failure. Journal of the American College of Cardiology. 41(6). 997–1003.
12.
Velazquez, Eric J., Marc A. Pfeffer, John J.V. McMurray, et al.. (2003). VALsartan In Acute Myocardial Infarction (VALIANT) Trial: Baseline Characteristics in Context. European Journal of Heart Failure. 5(4). 537–544.
13.
Gattis, Wendy A., Christopher M. O'Connor, Jeffrey D. Leimberger, et al.. (2003). Clinical outcomes in patients on beta-blocker therapy admitted with worsening chronic heart failure. The American Journal of Cardiology. 91(2). 169–174.
14.
Felker, G. Michael, Wendy A. Gattis, Jeffrey D. Leimberger, et al.. (2003). Usefulness of anemia as a predictor of death and rehospitalization in patients with decompensated heart failure. The American Journal of Cardiology. 92(5). 625–628.
15.
McCollum, S. Andy & Jeffrey D. Leimberger. (1997). Predator-induced morphological changes in an amphibian: predation by dragonflies affects tadpole shape and color. Oecologia. 109(4). 615–621.
16.
Talley, J. David, E. Magnus Ohman, Daniel B. Mark, et al.. (1997). Economic Implications of the Prophylactic Use of Intraaortic Balloon Counterpulsation in the Setting of Acute Myocardial Infarction. The American Journal of Cardiology. 79(5). 590–594.
17.
Gurbel, Paul A., Frank I. Navetta, Eric R. Bates, et al.. (1996). Lesion-directed administration of alteplase with intracoronary heparin in patients with unstable angina and coronary thrombus undergoing angioplasty. Catheterization and Cardiovascular Diagnosis. 37(4). 382–391.
18.
Barbagelata, Alejandro, Christopher B. Granger, Eric J. Topol, et al.. (1995). Frequency, significance, and cost of recurrent ischemia after thrombolytic therapy for acute Myocardial Infarction. The American Journal of Cardiology. 76(14). 1007–1013.
19.
Aguirre, Frank V., Eric J. Topol, Thomas J. Donohue, et al.. (1995). 901-14 Impact of Ionic and Non-ionic Contrast Media on Post-PTCA Ischemic Complications: Results from the EPIC Trial. Journal of the American College of Cardiology. 25(2). 8A–8A.
20.
Hillegass, William B., E. Magnus Ohman, Jeffrey D. Leimberger, & Robert M. Califf. (1994). A meta-analysis of randomized trials of calcium antagonists to reduce restenosis after coronary angioplasty. The American Journal of Cardiology. 73(12). 835–839.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Jan Skov Jensen Breakdown of academic impact, for papers by Carlo Lombardi Breakdown of academic impact, for papers by Shih‐Jen Hwang Breakdown of academic impact, for papers by Haldun Müderrisoğlu Breakdown of academic impact, for papers by Giovanni Parrinello Breakdown of academic impact, for papers by Patricia P. Chang Breakdown of academic impact, for papers by Patricia A. Peyser Breakdown of academic impact, for papers by Christina L. Wassel Breakdown of academic impact, for papers by Michelle J. Keyes Breakdown of academic impact, for papers by Jørgen Jeppesen